April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA103
Academic Journal
Clostridium difficile has been implicated in the relapse of patients with ulcerative colitis (UC) in India but other studies have suggested no association. Patients with UC relapse and coincident C difficile infection presenting during a 30 month period were identified from the hospital and microbiology laboratory databases. Information regarding treatment and outcome was extracted from casenotes. Although C. difficile treated, does not seem to worsen the with increased serum CRP and the usual can no longer infection, when appropriately outcome of UC, it is associated criteria for predicting colectomy be reliably applied.


Related Articles

  • Outcomes from Rectal Vancomycin Therapy in Patients With Clostridium difficile Infection. Saffouri, George; Khanna, Sahil; Estes, Lynn; Pardi, Darrell // American Journal of Gastroenterology;Jun2014, Vol. 109 Issue 6, p924 

    A letter to the editor in response to a research article related to the effectiveness of rectal vancomycin therapy in patients With clostridium difficile infection (CDI) published in a previous issue is presented.

  • Analysis of the Pathogenicity Locus in Clostridium difficile Strains. Cohen, Stuart H.; Tang, Yajarayma J.; Silva Jr., Joseph // Journal of Infectious Diseases;2/1/2000, Vol. 181 Issue 2, p659 

    Analyzes the pathogenicity locus in Clostridium difficile strains. Major virulence factors in Clostridium difficile-associated diarrhea; Components of the pathogenicity locus of Clostridium difficile; Role of the tcdC-E gene in the virulence of Clostridium difficile.

  • Recent advances in antibacterial drugs. Rai, Jaswant; Randhawa, Gurpreet Kaur; Kaur, Mandeep // International Journal of Applied & Basic Medical Research;Jan2013, Vol. 3 Issue 1, p3 

    The incidence of antimicrobial resistance is on continued rise with a threat to return to the "pre-antibiotic" era. This has led to emergence of such bacterial infections which are essentially untreatable by the current armamentarium of available treatment options. Various efforts have been made...

  • The Medicine of the Microbiome. Davis, Mark // Townsend Letter;Feb/Mar2015, Issue 379/380, p83 

    The article focuses on the use of the fecal microbiota transplantation (FMT) for treating ulcerative colitis (UC) patients. Topics discussed include FMT as a process of administering microorganisms of healthy donor's stool to a patient's gastrointestinal (GI) tract; FMT which is safe in case of...

  • Nitazoxanide for the Treatment of Clostridium difficile Colitis. Musher, Daniel M.; Logan, Nancy; Hamill, Richard J.; DuPont, Herbert L.; Lentnek, Arnold; Gupta, Arvind; Rossignol, Jean-Francois // Clinical Infectious Diseases;8/15/2006, Vol. 43 Issue 4, p421 

    Background. Clostridium difficile colitis has increased in incidence and severity, and treatment failure with metronidazole therapy has increasingly been documented. It is uncertain whether treatment with vancomycin is more effective than treatment with metronidazole, but concern over the...

  • Prevalence of Enterotoxin Producing Staphylococcus aureus in Stools of Patients with Nosocomial Diarrhea. Flemming, K.; Ackermann, G. // Infection;Oct2007, Vol. 35 Issue 5, p356 

    Nosocomial diarrhea causes prolonged hospital stay leading to additional diagnostic and therapeutic procedures resulting in higher costs. A total of 20%–25% of antibiotic-associated diarrhea (AAD) cases are attributed to Clostridium difficile. Other microorganisms like Clostridium...

  • Co-infection as a confounder for the role of Clostridium difficile infection in children with diarrhoea: a summary of the literature. Graaf, H.; Faust, S.; Pai, S.; Enoch, D.; Burns, D.; Karas, J. // European Journal of Clinical Microbiology & Infectious Diseases;Jul2015, Vol. 34 Issue 7, p1281 

    Although Clostridium difficile is a major cause of antibiotic-associated diarrhoea in adults, the incidence and severity of C. difficile infection (CDI) in children is unclear. One complicating factor in assessing the role of CDI in children is the possibility of co-infection with other...

  • Waiting for the human intestinal Eukaryotome. Andersen, Lee O'Brien; Vedel Nielsen, Henrik; Stensvold, Christen Rune // ISME Journal: Multidisciplinary Journal of Microbial Ecology;Jul2013, Vol. 7 Issue 7, p1253 

    No abstract available.

  • TcdC Does Not Significantly Repress Toxin Expression in Clostridium difficile 630ΔErm. Bakker, Dennis; Smits, Wiep Klaas; Kuijper, Ed J.; Corver, Jeroen; Popoff, Michel R. // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    In the past decade, Clostridium difficile has emerged as an important gut pathogen. Symptoms of C. difficile infection range from mild diarrhea to pseudomembranous colitis, sometimes resulting in colectomy or death. The main virulence factors of C. difficile are toxin A and toxin B. Besides...


Read the Article


Sign out of this library

Other Topics